Jorkasky Diane 4
4 · Altimmune, Inc. · Filed Jun 28, 2022
Insider Transaction Report
Form 4
Jorkasky Diane
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.0001
2022-06-27$3.15/sh+17,610$55,472→ 17,610 total - Exercise/Conversion
Stock Options (option to buy)
2022-06-27−17,610→ 22,390 totalExercise: $3.15Exp: 2030-05-11→ Common Stock, par value $0.0001 (40,000 underlying) - Sale
Common Stock, par value $0.0001
2022-06-27$11.75/sh−17,610$206,944→ 0 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.75 to $11.88, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The shares underlying the option become vested and exercisable in 36 substantially equal monthly installments, subject to the reporting person's continued service through the applicable vesting date.